ACCC Launches New Public Policy Website

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 1
Volume 11
Issue 1

ROCKVILLE, Maryland-The Association of Community Cancer Centers (ACCC) has launched a new website (www.accc-cancer.org/publicpolicy) dedicated to regulatory and legislative issues affecting patients with cancer. The website will assist in the education of patients and their families about public policy that affects cancer care.

ROCKVILLE, Maryland—The Association of Community Cancer Centers (ACCC) has launched a new website (www.accc-cancer.org/publicpolicy) dedicated to regulatory and legislative issues affecting patients with cancer. The website will assist in the education of patients and their families about public policy that affects cancer care.

The new website also was designed to serve as a tool to bring patients and physicians together to discuss important cancer issues, such as new therapeutic modalities, insurance reimbursement, and clinical trials. The public policy site features information for patients and their families regarding access to cancer care, and details on oral cancer drugs and the congressional actions affecting use of such drugs.

The site features a section on legislative alerts, general information about Capitol Hill legislators, and tips for patients with cancer and their families on communicating with their representatives. The site also provides a directory of ACCC member hospitals and physicians, a list of patient advocacy organizations, and contact information for representatives and senators.

"By providing patients and families with information about the public policies that impact cancer care and helping them learn about the legislative process, they will be able to fully act on their rights and enlist the government in their personal battles against cancer," said Margaret A. Riley, MN, RN, of ACCC’s Ad Hoc Committee for Advocacy. 

Recent Videos
Two experts are featured in this series.
Two experts are featured in this series.
According to John Henson, MD, “What we need are better treatments to control the [brain] tumor once it’s detected.”
First-degree relatives of patients who passed away from pancreatic cancer should be genetically tested to identify their risk for the disease.
2 experts are featured in this series.
2 experts are featured in this series.
Surgery and radiation chemotherapy can affect immunotherapy’s ability to target tumor cells in the nervous system, according to John Henson, MD.
Thinking about how to sequence additional agents following targeted therapy may be a key consideration in the future of lung cancer care.
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
Related Content